Use of Oxycodone in Bariatric Surgery
Summary
There is still no effective treatment for surgical pain, especially visceral pain in bariatric surgery. Oxycodone has great application prospect in patients with obesity, but there are few clinical studies and analgesic effect is still unclear, especially in combination with esketamine. This study was a prospective, single-center, randomized, controlled, double-blind clinical trial to compare the efficacy and safety of intravenous oxycodone and combined use of esketamine for perioperative multimodel analgesia during bariatric surgery, and the effect of esketamine on inflammatory factors. This study was based on the hypothesis that oxycodone and the combination use with esketamine can effectively reduce the level of postoperative pain and inflammatory factors, and does not increase perioperative adverse reactions in bariatric surgery.
Timeline
- Start
- 2022-10-01
- Primary completion
- 2024-04-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dezocine | Other / unclassified | 0.15 mg/kg | Intravenous |
| Comparator | Dezocine | Other / unclassified | 30 mg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.15 mg/kg | Intravenous |
| Subject | Oxycodone | Other / unclassified | 0.15 mg/kg | Intravenous |
| Subject | Oxycodone | Other / unclassified | 30 mg | Intravenous |
Indications
No indication recorded.